Activation of a code sepsis in the emergency department is associated with a decrease in mortality

Area of Science:

• Emergency Medicine
• Critical Care
• Sepsis Management

Background:

• Severe sepsis poses a significant threat in emergency settings.
• Adherence to established guidelines, such as the Surviving Sepsis Campaign (SSC), is crucial for improving patient outcomes.
• The impact of structured protocols like code sepsis (CS) activation on patient management and mortality requires evaluation.

Purpose of the Study:

• To assess the effectiveness of a code sepsis (CS) activation protocol in managing severe sepsis patients in the emergency room.
• To evaluate compliance with Surviving Sepsis Campaign (SSC) recommendations following CS activation.
• To identify independent factors associated with mortality in severe sepsis patients.

Main Methods:

• A 6-month prospective study included all emergency room patients with severe sepsis.
• Patients were divided into two groups: those with CS activation (Group A) and those without (Group NA).
• Key outcomes assessed included average length of stay, intensive care unit (ICU) admissions, and 30-day mortality.

Main Results:

• Code sepsis activation (Group A) was associated with more frequent hypotension, but also with higher rates of blood cultures drawn, early antibiotic administration, and fluid replacement.
• Patients in Group A showed better global achievement of CS objectives compared to Group NA.
• Group NA had significantly higher ICU admissions, longer average hospital stays, and a markedly higher 30-day mortality rate (34.1% vs 4.3%).
• Elevated C-reactive protein (CRP) levels and lack of CS activation were independent predictors of mortality.

Conclusions:

• Code sepsis activation significantly improves adherence to SSC recommendations for severe sepsis management.
• Implementation of a CS protocol leads to reduced intensive care unit admissions, shorter average hospital stays, and decreased mortality rates.
• Code sepsis activation is a critical intervention for improving outcomes in patients with severe sepsis.